On May 13 | Recursion (RXRX.US) rose 3.49% to $8.9 in the premarket. The company's Q1 earnings report achieved revenue of US$13.491 million. The previous value was US$12.134 million, and the expected value was US$12.65 million. Needham analyst Jill Blum reaffirmed Recursion's buy rating and maintained a target price of $17.
美股异动丨Recursion盘前涨超3% Q1营收超预期
US stock changes丨Recursion rose more than 3% in the premarket, Q1 revenue exceeded expectations
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.